Trainee Participation and Outcomes in High-risk Endoscopic Retrograde Cholangiopancreatography: A Secondary Analysis of the Stent Versus Indomethacin Trial

Stent Versus Indomethacin (SVI) Study Group

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
Pages (from-to)175-178.e2
JournalClinical Gastroenterology and Hepatology
Volume23
Issue number1
DOIs
StatePublished - Jan 2025

Funding

Funding This trial was supported by grant U01DK104833 from the National Institutes of Health. The findings are those of the authors and do not necessarily represent the official views of the National Institutes of Health. Conflicts of interest These authors disclose the following: Steven A. Edmundowicz reports consulting fees from Olympus; and honoraria from Boston Scientific. Nauzer Forbes reports consulting fees and payment or honoraria for lectures or receipt of equipment or materials from Boston Scientific and Pentax. Field F. Willingham reports consulting fees from Cook/Boston Scientific. Shyam Varadarajulu reports consulting fees from Boston Scientific/Olympus. Ji Young Bang reports consulting fees from Boston Scientific/Olympus. Mouen Khashab reports consulting fees from Boston Scientific. Rajesh Keswani reports consulting fees from Boston Scientific. Yen-I Chen reports consulting fees, honoraria, research grants, and travel payments from Boston Scientific. Alan Barkun reports financial interest in Olympus. Andrew Ross reports payment or honoraria for lectures or presentations and travel from Boston Scientific. The remaining authors disclose no conflicts.

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this